Christina Orsmark-Pietras

5PUBLICATIONS
14CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Innate immunityMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Medical biotechnology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 25, 2025
The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes.

Henrik Lilljebjörn, Pablo Peña-Martínez, Hanna Thorsson

|Oct 03, 2025
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia.

Carl Sandén, Niklas Landberg, Pablo Peña-Martínez

|Aug 06, 2024
TLE3 Is a Novel Fusion Partner of JAK2 in Myeloid/Lymphoid Neoplasm With Eosinophilia Responding to JAK2 Inhibition.

Vladimir Lazarevic, Henrik Lilljebjörn, Linda Olsson-Arvidsson

|Jul 20, 2024
Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture-Based Gene Panel.

Christina Orsmark-Pietras, Anna Lyander, Claes Ladenvall

Pageof 1